Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors?
fool.com·Jun 20, 2026
Eli Lilly is performing exceptionally well in the GLP-1 weight-loss market, resulting in significant stock gains, but its dividend yield is only 0.6%. In contrast, Pfizer offers a much higher dividend yield of 6.6%, despite facing challenges such as declining COVID vaccine sales and upcoming patent expirations, making it an attractive option for dividend-focused investors willing to accept some risk.
For a dividend-focused investor seeking substantial yield, Pfizer's current 6.6% dividend yield presents a compelling opportunity despite the company's recent challenges and high payout ratio. This yield is significantly higher than Eli Lilly's 0.6%, offering potential for substantial income while Pfizer navigates typical industry headwinds.